HIF induces human embryonic stem cell markers in cancer cells.
about
Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesisCancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer TherapyUsing Stem Cells to Grow Artificial Tissue for Peripheral Nerve RepairRetinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategiesGlioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic TargetsHypoxia-inducible factor 1-mediated characteristic features of cancer cells for tumor radioresistanceKey Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem CellsApplications of iPSCs in Cancer ResearchIncreased Oxidative Stress as a Selective Anticancer TherapyMolecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancersTargeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressivenessReprogramming of gastrointestinal cancer cellsProstate Cancer Stem Cells: Research AdvancesBrain tumor stem cells: Molecular characteristics and their impact on therapyNovel delivery strategies for glioblastomaAdvances and Challenges on Cancer Cells Reprogramming Using Induced Pluripotent Stem Cells TechnologiesIn vitro models of cancer stem cells and clinical applicationsHypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to HypoxiaConcise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding QuestionsHypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cellsHypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatmentTime-dependent stabilization of hypoxia inducible factor-1α by different intracellular sources of reactive oxygen speciesNanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W speciesActivation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective.Metabolic tumor profiling with pH, oxygen, and glucose chemosensors on a quantum dot scaffold.Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302.Relationship between Apparent Diffusion Coefficients and MR Spectroscopy Findings in High-Grade Gliomas.Hypoxia-inducible factors have distinct and stage-specific roles during reprogramming of human cells to pluripotency.The Transcription Regulator Krüppel-Like Factor 4 and Its Dual Roles of Oncogene in Glioblastoma and Tumor Suppressor in Neuroblastoma.Musashi-1 promotes a cancer stem cell lineage and chemoresistance in colorectal cancer cells.HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxiaA proposed quantitative index for assessing the potential contribution of reprogramming to cancer stem cell kinetics.HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells.Emerging role of nanog in tumorigenesis and cancer stem cells.Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity.Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signalingBiomarkers to Target Heterogeneous Breast Cancer Stem CellsInduced pluripotent stem cell: A headway in reprogramming with promising approach in regenerative biologyMetabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cellsAssessment of hypoxia inducible factor levels in cancer cell lines upon hypoxic induction using a novel reporter construct
P2860
Q21134097-5332849F-0853-4C08-B6FE-6EF8A4D64EB3Q26740207-003D95E2-13A5-40A4-8072-047A7F5004A2Q26747035-72E6EA5C-447B-4144-867D-79A4394B38FBQ26750380-4625F757-09A4-40DE-8FDA-CE86EA8CACF5Q26765758-DE4F550D-7E67-4C43-85E0-46766295E1B8Q26779535-9386FBA8-0B44-4D06-A406-E492C5A28322Q26795737-4BE38DCF-C9D2-4B41-889F-6114EF5C8AB3Q26798036-F8DBB20C-D425-4EB3-A3A5-B6E236F7BE28Q26798210-5459B3C3-599A-4893-9F0F-94BA9FE56284Q26822406-309E5E78-3838-4E01-85EF-95F929988B43Q26822776-2FA3A699-D1AF-42CB-A6D6-AEE4CF29E099Q26824284-50285B3A-E3E8-4749-B39C-FE5F5CFC7D89Q26998435-F6F88E69-6D13-4C3F-B7C5-4A10BB844FE6Q27003138-7093118E-1FFD-4A4A-AFE7-FB9B93E4D1BDQ27006099-5477DE69-4ECC-4C73-84FF-0354D25B9C17Q28071879-16795234-84FF-4C41-AF64-4DFC79E5B286Q28076101-7C1889A6-780B-4524-AC39-C2438263E5C9Q28085029-93516BD8-F1A0-4B3A-8F41-2FE1F30A2E5DQ28088370-16D33736-7332-4280-B3D6-3AC4DD907F16Q28393898-3FB9F88F-45FF-49A0-8AEA-7CA3FCC73E61Q28484357-08462A37-3609-4FEA-8A48-DA43166E3A3AQ28484609-5ADAF4FC-FE3B-4D59-8691-88CB5C10A3C2Q28540510-8BC5202B-D625-413F-9538-03DD21BD4488Q30276803-3A54F544-6C90-41E9-8BD5-FD63F8AAD086Q30573562-5FB6D48E-418A-4045-B7BA-F7849BBF00A2Q30826843-AE4BBDF6-54A0-4D04-AA22-D64E6D8FC07DQ31077412-5F30316B-72A4-4C6A-A249-16B4D618784CQ33637916-9F4AF25B-B8A4-4398-A8CD-A36198BE3DA4Q33652886-3C3B3114-39CB-4F2B-9038-7BF01A507115Q33708609-8CE6440C-36E1-43FF-9CD3-5B48F16C99F9Q33709584-D4CA5C2F-FD98-44D3-BA7E-982A10EA1BEBQ33737808-7556AE16-A5E7-4098-930F-B9CDBB074314Q33760690-C8F6B5D6-DC89-4356-B786-D54E27C4CB1BQ33786554-467EA682-6752-477D-816A-B8D754E9BAAAQ33786677-4AE9AAF0-F538-4470-B135-8E638255DB50Q33789920-65833C7E-9A6A-4B6D-8793-352175034957Q33811149-59E3F665-44A1-4AA6-A390-3A5006170864Q33877155-BC0138A3-C623-446E-92AF-E84E6F03DD23Q33895232-EAEA8DCB-7596-40DA-B6AA-2B855D89269DQ34087726-F69D3EAC-892F-4874-BED3-82823060750F
P2860
HIF induces human embryonic stem cell markers in cancer cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
HIF induces human embryonic stem cell markers in cancer cells.
@ast
HIF induces human embryonic stem cell markers in cancer cells.
@en
type
label
HIF induces human embryonic stem cell markers in cancer cells.
@ast
HIF induces human embryonic stem cell markers in cancer cells.
@en
prefLabel
HIF induces human embryonic stem cell markers in cancer cells.
@ast
HIF induces human embryonic stem cell markers in cancer cells.
@en
P2093
P2860
P1433
P1476
HIF induces human embryonic stem cell markers in cancer cells
@en
P2093
Alexis Hubaud
Amy J Wang
Bradford Stadler
C Anthony Blau
Carol Ware
Donald Born
Hannele Ruohola-Baker
Jeremy N Rich
John M Heddleston
P2860
P304
P356
10.1158/0008-5472.CAN-10-3320
P407
P577
2011-06-28T00:00:00Z